View CymaBay Therapeutics (NASDAQ:CBAY) historical prices, past price performance, and an advanced CBAY stock chart at MarketBeat.22 hours ago · CymaBay Therapeutics, Inc. (NASDAQ:CBAY – Get Free Report) hit a new 52-week high on Friday .The company traded as high as $32.25 and last traded at $32.25, with a volume of 393580 shares ...4 days ago · A high-level overview of CymaBay Therapeutics, Inc. (CBAY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference betwe...Stock Price Forecast. The 10 analysts with 12-month price forecasts for CBAY stock have an average target of 24.1, with a low estimate of 15 and a high estimate of 34. The average target predicts a decrease of …Cymabay Therapeu stock price (CBAY) NASDAQ: CBAY. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Cymabay Therapeu stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.CymaBay Therapeutics Stock Earnings. The value each CBAY share was expected to gain vs. the value that each CBAY share actually gained. CymaBay Therapeutics ( CBAY) reported Q3 2023 earnings per share (EPS) of -$0.32, missing estimates of -$0.29 by 10.04%. In the same quarter last year, CymaBay Therapeutics 's earnings per share …The CymaBay Therapeutics 52-week low stock price is 7.26, which is 77.5% below the current share price. The average CymaBay Therapeutics stock price for the last 52 weeks is 14.09. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide. CymaBay Therapeutics Inc. is a biopharmaceutical company.CymaBay Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ... Stock Price Target CBAY. High $ 36.00: Median $ 28.00: Low $ 20.00: Average $ 28.42: Current ... Feb 12, 2024 ... This has Gilead valuing shares of CBAY stock at $32.50 apiece. CBAY Stock - Why is CymaBay (CBAY) Stock Up 25% Today? Source: Sundry Photography ...CBAY enters Uptrend as Momentum indicator ascends above 0 level This indicator may be signaling that CBAY's price has momentum to move higher, since its current price …What's Happening with CBAY Stock Today CymaBay Therapeutics Inc (CBAY) stock is up 2.44% while the S&P 500 has risen 0.75% as of 12:15 PM on Thursday, Dec 7. CBAY has risen $0.51 from the previous closing price of $20.86 on volume of 582,850 shares. Over the past year the S&P 500 has risen 16.51% while CBAY has risen …Feb 15, 2024 · (CBAY Quick Quote CBAY - Free Report) , for $32.50 per share in cash or a total equity value of $4.3 billion. Shares of CBAY surged on the acquisition news as the offer price represents 27% of the ... Feb 18, 2024 · Summary of all time highs, changes and price drops for CymaBay Therapeutics; Historical stock prices; Current Share Price: US$32.19: 52 Week High: US$32.24 Open a brokerage account and deposit funds in it to purchase stock in a company, explains the Wall Street Journal. Companies such as Charles Schwab, E-Trade, and Ameritrade provide...Today, it's easy to get free stocks! In most cases, all you have to do is sign up for one of the investing apps on this list. Getting free stocks is simple - all you have to do is ...22 hours ago · CymaBay Therapeutics, Inc. (NASDAQ:CBAY – Get Free Report) hit a new 52-week high on Friday .The company traded as high as $32.25 and last traded at $32.25, with a volume of 393580 shares ...CymaBay Therapeutics Stock Forecast 2023. In the last five quarters, CymaBay Therapeutics’s Price Target has risen from $8.75 to $27.73 - a 216.91% increase. Ten analysts predict that CymaBay Therapeutics’s share price will increase in the coming year, reaching $32.50. This would represent an increase of 17.2%.What happened. Shares of CymaBay Therapeutics ( CBAY 2.92%) were up more than 37% as of 11:15 a.m. ET on Friday. The clinical-stage biotech saw its shares rise after Ipsen and Genfit announced ...Daniel Menold, Vice President, Finance of CymaBay Therapeutics Inc (NASDAQ:CBAY), has sold 10,000 shares of the company on January 16, 2024, according to a recent SEC …3 days ago · CBAY stock jumped 3.5% the day Genfit and Ipsen reported these results on Nov. 13. Genfit shares eked out a fractional gain. ... *Real-time prices by Nasdaq Last Sale. Realtime quote and/or trade ...CymaBay Therapeutics Inc. (CBAY Quick Quote CBAY - Free Report) closed the last trading session at $16.44, gaining 15.2% over the past four weeks, but there could be plenty of upside left in the ...23.65 -0.09 -0.38% Healthcare • Biotechnology • USA • NASD Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert Draw Ideas Candle - advanced Intraday …4 days ago · A high-level overview of CymaBay Therapeutics, Inc. (CBAY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 3 days ago ... Latest CBAY News along with Price and Volume Analysis CBAY Stock Analysis $CBAY Latest News TickerDD. 1 view · 3 minutes ago ...more. TickerDD.CymaBay Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ... Stock Price Target CBAY. High $ 32.50: Median $ 32.50: Low $ 20.00: Average $ 29.06: Current ...What happened. Shares of CymaBay Therapeutics ( CBAY 2.92%) were up more than 37% as of 11:15 a.m. ET on Friday. The clinical-stage biotech saw its shares rise after Ipsen and Genfit announced ...The CymaBay Therapeutics stock forecast for tomorrow is $ 25.72, which would represent a 0.13% gain compared to the current price. In the next week, the price of CBAY is expected to decrease by -2.50% and hit $ 25.05.. As far as the long-term CymaBay Therapeutics stock forecast is concerned, here’s what our predictions are currently suggesting.CBAY shares declined -4.5% the day following the earnings announcement to close at 15.70. Following its earnings release, 80 days ago, CBAY stock has drifted + ...Sep 15, 2019 · Get the latest CymaBay Therapeutics Inc. (CBAY) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Daniel Menold, Vice President, Finance of CymaBay Therapeutics Inc (NASDAQ:CBAY), has sold 10,000 shares of the company on January 16, 2024, according to a recent SEC Filing. Find the latest CymaBay Therapeutics, Inc. (CBAY) stock quote, history, news and other vital information to help you with your stock trading and investing.Feb 12, 2024 · Feb 12 (Reuters) - Gilead Sciences (GILD.O), opens new tab has agreed to buy CymaBay Therapeutics (CBAY.O), opens new tab for $4.3 billion, gaining access to an experimental liver disease ...Today, it's easy to get free stocks! In most cases, all you have to do is sign up for one of the investing apps on this list. Getting free stocks is simple - all you have to do is ...Find the latest CymaBay Therapeutics, Inc. (CBAY) stock quote, history, news and other vital information to help you with your stock trading and investing.Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest...Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods th...The company’s stock reached a 1-year high of $32.24 on 02/12/24, while the lowest price for the same period was registered at $7.26 on 06/27/23. 52-week price history of CBAY Stock. A stock’s 52-week high and low prices can reveal much about its current status and future trajectory.In depth view into CBAY (CymaBay Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. CymaBay Therapeutics Inc (CBAY) 23.80 -0.02 ( -0.06% ) USD | NASDAQ | Feb 05, 13:04 CBAY shares declined -4.5% the day following the earnings announcement to close at 15.70. Following its earnings release, 80 days ago, CBAY stock has drifted + ...Feb 9, 2024 · NASDAQ: CBAY · IEX Real-Time Price · USD. Add to Watchlist 24.95 +0.95 (3.96%) Feb 8, 2024, 3:03 PM EST - Market open. Overview; Financials; Statistics; Forecast; Dividends; Profile; Chart; Statistics; Market Cap; Revenue; CymaBay Therapeutics Revenue. CymaBay Therapeutics had revenue of $31.02M in the twelve …Feb 12, 2024 ... ... CBAY stock via a tender offer. That's a 27% premium compared to the stock's closing price last Friday. Gilead Sciences is acquiring CymaBay ...CymaBay Therapeutics (CBAY) Stock Price, News & Analysis $32.18 -0.02 (-0.06%) (As of 02/16/2024 ET) Compare Today's Range $32.12 $32.19 50-Day Range …2 days ago · CBAY is the ticker symbol for CymaBay Therapeutics Inc., a biotech company that develops treatments for rare liver diseases. The stock price, news, analysis, and ratings are updated on a delayed basis. As of Jan 25, 2024 7:59 p.m. EST, the stock closed at $22.23, down 1.02% from the previous day. Find the latest eBay Inc. (EBAY) stock quote, history, news and other vital information to help you with your stock trading and investing. Discover real-time eBay Inc. Common Stock (EBAY) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.Stock Price Statistics The stock price has increased by +301.00% in the last 52 weeks. The beta is 0.28, so CBAY's price volatility has been lower than the market average.Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may...Dec 28, 2023 ... CymaBay Therapeutics (CBAY) is sprinting to the finish line with a breakthrough treatment for a serious liver disease. And it's pushing CBAY ...Discover historical prices for CBAY stock on Yahoo Finance. View daily, weekly or monthly format back to when CymaBay Therapeutics, Inc. stock was issued. This has it agreeing to pay $32.50 per share in cash for CBAY stock via a tender offer. That’s a 27% premium compared to the stock’s closing price last Friday.Feb 13, 2024 · CymaBay Therapeutics (CBAY) CymaBay Therapeutics received a Hold rating and a $32.50 price target from H.C. Wainwright analyst Ed Arce today. The company’s shares closed last Monday at $32.21 ...CBAY CymaBay Therapeutics, Inc.Stock Price & Overview. 7.36K followers. $32.19 -0.01 ( -0.03%) 4:00 PM 02/21/24. NASDAQ | $USD | Post-Market: $32.16 -0.03 ( …The CymaBay Therapeutics 52-week low stock price is 7.26, which is 77.5% below the current share price. The average CymaBay Therapeutics stock price for the last 52 weeks is 14.09. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide. CymaBay Therapeutics Inc. is a biopharmaceutical company. At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.Feb 12, 2024 ... This has Gilead valuing shares of CBAY stock at $32.50 apiece. CBAY Stock - Why is CymaBay (CBAY) Stock Up 25% Today? Source: Sundry Photography ...Find the latest Absci Corporation (ABSI) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest Absci Corporation (ABSI) stock quote, history, news and other vital information to help you with your stock trading and investing.CymaBay Therapeutics Inc. (CBAY) closed the last trading session at $16.44, gaining 15.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price ...CBAY enters Uptrend as Momentum indicator ascends above 0 level This indicator may be signaling that CBAY's price has momentum to move higher, since its current price …Dec 5, 2022 ... ... cbay a good stock to buy, also is cbay a buy or sell? While analyzing cbay stock price target or doing the cbay stock review, it is ...CBAY enters Uptrend as Momentum indicator ascends above 0 level This indicator may be signaling that CBAY's price has momentum to move higher, since its current price exceeds the price logged 14 days ago. Traders may consider buying the stock or exploring call options. CymaBay Therapeutics Stock Earnings. The value each CBAY share was expected to gain vs. the value that each CBAY share actually gained. CymaBay Therapeutics ( CBAY) reported Q3 2023 earnings per share (EPS) of -$0.32, missing estimates of -$0.29 by 10.04%. In the same quarter last year, CymaBay Therapeutics 's earnings per share …Cymabay Therapeutics stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... CBAY Stock Quotes API ... CBAY is a clinical-stage biopharmaceutical company that develops therapies for liver and other chronic diseases. The stock price, quote, news and analysis of CBAY are updated daily on this web page. …Feb 12, 2024 ... Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of CymaBay Therapeutics, Inc. to Gilead Sciences, ...View the latest CBAY earnings date, analysts forecasts, earnings history, and conference call transcripts. Skip to main content. S&P 500 5,088.80. DOW 39,131.53. ...Dec 18, 2023 ... CymaBay Therapeutics Inc (CBAY) stock is lower by -2.32% while the S&P 500 is up 0.28% as of 9:53 AM on Monday, Dec 18. CBAY is lower by -$0.51 ...CymaBay Therapeutics Inc is a clinical-stage biopharmaceutical company. Its main business involves the development of therapeutics such as Arhalofenate, MBX-8025, and MBX-2982. These drugs are intended to treat serious metabolic disorders. Arhalofenate is used to treat gout, MBX-2982 is an oral, G-protein coupled receptor agonist being ...Find the latest CymaBay Therapeutics, Inc. (CBAY) stock quote, history, news and other vital information to help you with your stock trading and investing.View the latest CBAY earnings date, analysts forecasts, earnings history, and conference call transcripts. Skip to main content. S&P 500 5,088.80. DOW 39,131.53. ...Cymabay Therapeu stock price (CBAY) NASDAQ: CBAY. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Cymabay Therapeu stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.Shares of CBAY surged 25.8% on the acquisition news as the offer price represents 27% of the company’s closing share price as of Feb 9, 2024. Financial Terms of the AcquisitionCymabay Therapeu stock price (CBAY) NASDAQ: CBAY. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Cymabay Therapeu stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Select a stock. apple; wise; Select a currency. USD. …Stock Data. Quote · Charts · Historical Data · Analyst Coverage. Charting. CymaBay Therapeutics Inc. Nasdaq Global Select: CBAY. Events. Earnings. Dividends.Oct 15, 2020 · About the CymaBay Therapeutics, Inc. stock forecast. As of 2024 January 16, Tuesday current price of CBAY stock is 23.760$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Cymabay Therapeutics stock price as been showing a rising tendency so we believe that similar market …CymaBay Therapeutics (CBAY) Stock Price, News & Analysis $32.18 -0.02 (-0.06%) (As of 02/16/2024 ET) Compare Today's Range $32.12 $32.19 50-Day Range …This has it agreeing to pay $32.50 per share in cash for CBAY stock via a tender offer. That’s a 27% premium compared to the stock’s closing price on Friday. Gilead Sciences is acquiring ...Here's why making dividend investing a primary strategy as you build your retirement portfolio may not be the best decision. Is building a dividend portfolio a good idea, and what ...Based on 7 Wall Street analysts offering 12 month price targets for CymaBay Therapeutics in the last 3 months. The average price target is $28.67 with a high forecast of $36.00 and a low forecast of $20.00. The average price target represents a 20.61% change from the last price of $23.77. Highest Price Target $36.00. Average Price Target $28.67.Shares of CBAY surged 25.8% on the acquisition news as the offer price represents 27% of the company’s closing share price as of Feb 9, 2024. Financial Terms of the AcquisitionDec 5, 2022 ... ... cbay a good stock to buy, also is cbay a buy or sell? While analyzing cbay stock price target or doing the cbay stock review, it is ...CymaBay Therapeutics Inc. (CBAY) closed the last trading session at $16.44, gaining 15.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price ...The average one-year price target for Cymabay Therapeutics (NASDAQ:CBAY) has been revised to 18.28 / share. This is an increase of 17.10% from the prior estimate of 15.61 dated August 1, 2023.Feb 13, 2024 · Detailed statistics for CymaBay Therapeutics, Inc. (CBAY) stock, including valuation metrics, financial numbers, share information and more. ... Stock Price Statistics. The stock price has increased by +301.00% in the last 52 weeks. The beta is 0.28, so CBAY's price volatility has been lower than the market average.Aug 14, 2023 · CymaBay Therapeutics stock price target raised to $16 from $8 at B. Riley MarketWatch. Wednesday, May 18, 2022. 07:27 AM ET. CymaBay Therapeutics stock price target cut to $8 from $10 at B. Riley MarketWatch. Wednesday, May 13, 2020. 07:47 AM ET. CymaBay Therapeutics stock price target raised to $6.00 from $1.50 at B. Riley FBR …Feb 12, 2024 · This has it agreeing to pay $32.50 per share in cash for CBAY stock via a tender offer. That’s a 27% premium compared to the stock’s closing price last Friday. 4 days ago · A high-level overview of CymaBay Therapeutics, Inc. (CBAY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Jun 30, 2023 · What happened. Shares of CymaBay Therapeutics ( CBAY -0.06%) were up more than 37% as of 11:15 a.m. ET on Friday. The clinical-stage biotech saw its shares rise after Ipsen and Genfit announced ... CBAY, for $32.50 per share in cash or a total equity value of $4.3 billion. Shares of CBAY surged on the acquisition news as the offer price represents 27% of the …Cymabay Therapeu stock price (CBAY) NASDAQ: CBAY. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Cymabay Therapeu stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Select a stock.What's Happening with CBAY Stock Today CymaBay Therapeutics Inc (CBAY) stock is up 2.44% while the S&P 500 has risen 0.75% as of 12:15 PM on Thursday, Dec 7. CBAY has risen $0.51 from the previous closing price of $20.86 on volume of 582,850 shares. Over the past year the S&P 500 has risen 16.51% while CBAY has risen …Cbay stock price
The latest price target for CymaBay Therapeutics ( NASDAQ: CBAY) was reported by HC Wainwright & Co. on Friday, December 15, 2023. The analyst firm set a price target for 28.00 expecting CBAY to ...Feb 12, 2024 · CymaBay stock skyrocketed Monday after Gilead Sciences announced it will buy it for $4.3 billion. CBAY stock surged almost 25%. ... Realtime quote and/or trade prices are not sourced from all markets. Cymabay Therapeu stock price (CBAY) NASDAQ: CBAY. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. ... Cymabay Therapeu stock (CBAY) in USD. 1 CBAY = 24 USD. 1 month. 6 months. 1 year. 5 years. Cymabay Therapeu stock performance at a glance. Check Cymabay Therapeu’s past …In 2016, MSI acquired UK-based Airwave Systems. Find the latest Cal Bay International, Inc. (CBYI) stock quote, history, news and other vital information to help you with your stock trading and ...Ticker Symbol: CBAY: Exchange: NASDAQ: Fiscal Year: January - December: Reporting Currency: USD: CIK Code: 0001042074: CUSIP Number: 23257D103: ISIN Number: US23257D1037Nov 14, 2023 · This strengthens the case for CBAY’s potential in the rapidly expanding PBC therapeutics market. In another report released today, Piper Sandler also maintained a Buy rating on the stock with a ... 2 days ago · The Cymabay Therapeutics Inc stock price fell by -0.279% on the last day (Tuesday, 13th Feb 2024) from $32.21 to $32.12. During the last trading day the stock fluctuated 0.374% from a day low at $32.09 to a day high of $32.21. The price has risen in 6 of the last 10 days and is up by 35.81% over the past 2 weeks. Looking at CBAY's stock performance, it is evident that investors have responded positively to the recent news and analyst ratings. Since the company's last quarterly report on June 30, 2023, the stock price has surged by an impressive 48.3%. On a year-over-year basis, CBAY has seen a remarkable increase of 328.5%. …Dec 5, 2022 ... ... cbay a good stock to buy, also is cbay a buy or sell? While analyzing cbay stock price target or doing the cbay stock review, it is ...CBAY is a clinical-stage biopharmaceutical company that develops therapies for liver and other chronic diseases. The stock price, quote, news and analysis of CBAY are updated daily on this web page. …CBAY is the ticker symbol for CymaBay Therapeutics Inc., a biotech company that develops treatments for rare liver diseases. The stock price, news, analysis, and …View CymaBay Therapeutics, Inc. CBAY stock quote prices, financial information, real-time forecasts, and company news from CNN. 0. These 5 analysts have an average price target of $12.8 versus the current price of CymaBay Therapeutics at $10.4, implying upside. Below is a summary of how these 5 analysts rated CymaBay ...Feb 14, 2024 ... MEGA BREAKOUT : CBAY STOCK ANALYSIS | CYMABAY THERAPEUTICS STOCK. 17 ... Price Action Trading like a Pro - I share my best tips after 14 years.Webull offers CBAY Ent Holdg (CBAY) historical stock prices, in-depth market analysis, NASDAQ: CBAY real-time stock quote data, in-depth charts, free CBAY options chain data, and a fully built financial calendar to help you invest smart. Buy CBAY stock at Webull.Is CymaBay Therapeutics Stock Undervalued? The current CymaBay Therapeutics [CBAY] share price is $32.21. The Score for CBAY is 100, which is 100% above its ...Based on our forecasts, a long-term increase is expected, the "CBAY" stock price prognosis for 2029-02-14 is 68.101 USD. With a 5-year investment, the revenue is expected to be around +111.26%. Your current $100 investment may be up to $211.26 in 2029. [60% OFF VIP SALE] Portfolio is UP +117% in 2023 - Try Now Risk-Free - Money-back guarantee! ...Feb 16, 2024 · The latest CymaBay Therapeutics stock prices, stock quotes, news, and CBAY history to help you invest and trade smarter. Based on 7 Wall Street analysts offering 12 month price targets for CymaBay Therapeutics in the last 3 months. The average price target is $28.67 with a high forecast of $36.00 and a low forecast of $20.00. The average price target represents a 20.61% change from the last price of $23.77. Highest Price Target $36.00. Average Price Target $28.67.Stock analysis for Cymabay Therapeutics Inc (CBAY:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Nov 19, 2023 · Read why CBAY stock is a hold. ... seven analyst firms including Piper Sandler and BTIG have reissued or assigned Buy/Outperform ratings on the stock. Price targets proffered range from $21 to $33 ... Find the latest CymaBay Therapeutics, Inc. (CBAY) stock quote, history, news and other vital information to help you with your stock trading and investing. These 14 analysts have an average price target of $22.93 versus the current price of CymaBay Therapeutics at $16.55, implying upside. Below is a summary of how these 14 analysts rated CymaBay ...Aug 18, 2020 · Find the latest CymaBay Therapeutics, Inc. (CBAY) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. ... Nasdaq 15,580.87-49.91 ...Feb 12, 2024 ... This has Gilead valuing shares of CBAY stock at $32.50 apiece. CBAY Stock - Why is CymaBay (CBAY) Stock Up 25% Today? Source: Sundry Photography ...The Cymabay Therapeutics Inc stock price fell by -0.279% on the last day (Tuesday, 13th Feb 2024) from $32.21 to $32.12. During the last trading day the stock fluctuated 0.374% from a day low at $32.09 to a day high of $32.21. The price has risen in 6 of the last 10 days and is up by 35.81% over the past 2 weeks.CymaBay Therapeutics Inc. (CBAY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.Jun 30, 2023 ... The clinical-stage biotech saw its shares rise after Ipsen and Genfit announced phase 3 trials data for elafibranor to treat the rare autoimmune ...The latest price target for CymaBay Therapeutics ( NASDAQ: CBAY) was reported by HC Wainwright & Co. on Friday, December 15, 2023. The analyst firm set a price target for 28.00 expecting CBAY to ...Interactive stock price chart for CymaBay Therapeutics, Inc. (CBAY) with real-time updates, full price history, technical analysis and more.Fiscal Q3 2023 ended 9/30/23. Reported on 11/6/23. Get the latest CymaBay Therapeutics Inc (CBAY) real-time quote, historical performance, charts, and other financial …Jan 14, 2024 · CBAY Historical Data. ... Get up to 10 years of daily historical stock prices & volumes. Data provided by Edgar Online. ©2021, EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR ...This has it agreeing to pay $32.50 per share in cash for CBAY stock via a tender offer. That’s a 27% premium compared to the stock’s closing price last Friday. Gilead Sciences is acquiring CymaBay for its lead product candidate, seladelpar. This is a treatment in development to treat primary biliary cholangitis (PBC). Gilead Sciences …CBAY ranks lowest in Stability; there it ranks in the 2nd percentile. CBAY Stock Summary. The capital turnover (annual revenue relative to shareholder's equity) for CBAY is 0.1 -- better than just 13.13% of US stocks. With a price/sales ratio of 84.02, CYMABAY THERAPEUTICS INC has a higher such ratio than 97.51% of stocks in our set.CBAY shares declined -4.5% the day following the earnings announcement to close at 15.70. Following its earnings release, 80 days ago, CBAY stock has drifted + ...Track Cymabay Therapeutics Inc (CBAY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors The latest price target for . CymaBay Therapeutics (NASDAQ: CBAY) was reported by HC Wainwright & Co. on December 15, 2023.The analyst firm set a price target for $28.00 expecting CBAY to rise to ...CBAY stock jumped 3.5% the day Genfit and Ipsen reported these results on Nov. 13. Genfit shares eked out a fractional gain. ... Realtime quote and/or trade prices are not sourced from all markets. Feb 15, 2024 · (CBAY Quick Quote CBAY - Free Report) , for $32.50 per share in cash or a total equity value of $4.3 billion. Shares of CBAY surged on the acquisition news as the offer price represents 27% of the ... Feb 12, 2024 ... This has Gilead valuing shares of CBAY stock at $32.50 apiece. CBAY Stock - Why is CymaBay (CBAY) Stock Up 25% Today? Source: Sundry Photography ...Real-time Price Updates for Cymabay Therapeutics (CBAY-Q), along with buy or sell indicators, analysis, charts, historical performance, news and moreVinFast Auto Ltd. Ordinary Shares. $17.15 -0.84 -4.67%. CymaBay Therapeutics Inc. Common Stock (CBAY) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data ... Sep 8, 2023 · He kept his outperform rating on CBAY stock and raised his price target to 20 from 18. Notably, CymaBay stock has a best-possible Relative Strength Rating of 99, according to IBD Digital. This ... CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA. View CymaBay Therapeutics, Inc. CBAY stock quote prices, financial information, real-time forecasts, and company news from CNN. Today, it's easy to get free stocks! In most cases, all you have to do is sign up for one of the investing apps on this list. Getting free stocks is simple - all you have to do is ...48.33M. MSFT. 404.06. -0.61%. 21.64M. View today's Cymabay Therapeu stock price and latest CBAY news and analysis. Create real-time notifications to follow any changes in the live stock price.17.62. 17.62. 6,577,800. *Close price adjusted for splits. **Close price adjusted for splits and dividend and/or capital gain distributions. Discover historical prices for CBAY stock on Yahoo Finance. View daily, weekly or monthly formats back to when CymaBay Therapeutics, Inc. stock was issued.Find the latest CymaBay Therapeutics, Inc. (CBAY) stock quote, history, news and other vital information to help you with your stock trading and investing. Open a brokerage account and deposit funds in it to purchase stock in a company, explains the Wall Street Journal. Companies such as Charles Schwab, E-Trade, and Ameritrade provide...View CymaBay Therapeutics, Inc. CBAY stock quote prices, financial information, real-time forecasts, and company news from CNN. Feb 13, 2024 · Cymabay Therapeutics 's market cap is calculated by multiplying CBAY's current stock price of $32.12 by CBAY's total outstanding shares of 113,403,353. At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.Feb 15, 2024 · (CBAY Quick Quote CBAY - Free Report) , for $32.50 per share in cash or a total equity value of $4.3 billion. Shares of CBAY surged on the acquisition news as the offer price represents 27% of the ... This has it agreeing to pay $32.50 per share in cash for CBAY stock via a tender offer. That’s a 27% premium compared to the stock’s closing price last Friday. Gilead Sciences is acquiring CymaBay for its lead product candidate, seladelpar. This is a treatment in development to treat primary biliary cholangitis (PBC). Gilead Sciences …22 hours ago · CymaBay Therapeutics, Inc. (NASDAQ:CBAY – Get Free Report) hit a new 52-week high on Friday .The company traded as high as $32.25 and last traded at $32.25, with a volume of 393580 shares ...Get CymaBay Therapeutics Inc (CBAY.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsThe company’s stock reached a 1-year high of $32.24 on 02/12/24, while the lowest price for the same period was registered at $7.26 on 06/27/23. 52-week price history of CBAY Stock. A stock’s 52-week high and low prices can reveal much about its current status and future trajectory.Company Profile. CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. The company is headquartered in Newark California, California and currently employs 60 full-time employees. The company went IPO on 2014-01-16.. Speed demon